Filing Details

Accession Number:
0001209191-14-033121
Form Type:
4
Zero Holdings:
No
Publication Time:
2014-05-12 20:23:39
Reporting Period:
2014-05-08
Filing Date:
2014-05-12
Accepted Time:
2014-05-12 20:23:39
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1088856 Corcept Therapeutics Inc CORT Pharmaceutical Preparations (2834) 770487658
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1236397 Daniel Bradbury C/O Corcept
149 Commonwealth Drive
Menlo Park CA 94025
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2014-05-09 125,000 $1.79 304,000 No 4 P Indirect BioBrit,LLC.
Common Stock Acquisiton 2014-05-12 13,925 $1.83 317,925 No 4 P Indirect BioBrit, LLC.
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect BioBrit,LLC.
No 4 P Indirect BioBrit, LLC.
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock option (right to buy) Acquisiton 2014-05-08 30,000 $1.74 30,000 $1.74
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
30,000 2024-05-08 No 4 A Direct
Footnotes
  1. Represents the average price per share
  2. Exercisable with respect to 8.3334% of the total option shares on each monthly anniversary of May 8, 2014, with the final vesting of all remaining shares to occur on or before the date of Corcept's 2015 Annual Meeting of Stockholders.